Antibody-drug conjugate
Showing 9976 - 10000 of >10,000
UVB Phototherapy Burn, Insulin-like Growth Factor 1, Aging Trial in Fairborn (Insulin-Like Growth Factor 1, No Insulin-Lie
Recruiting
- UVB Phototherapy Burn
- +2 more
- Insulin-Like Growth Factor 1
- No Insulin-Lie Growth Factor 1
-
Fairborn, OhioWright State Physicians
Jan 9, 2023
Solid Tumors Harboring NTRK Fusion Trial in United States (Larotrectinib (Vitrakvi, BAY2757556))
Completed
- Solid Tumors Harboring NTRK Fusion
- Larotrectinib (Vitrakvi, BAY2757556)
-
Aurora, Colorado
- +7 more
May 11, 2021
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric,
Active, not recruiting
- Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
- Trastuzumab deruxtecan
-
Santa Rosa, California
- +29 more
Jun 14, 2022
Nasopharyngeal Carcinoma Trial (GP+Peramprizumab+Anlotinib, GP+Peramprizumab)
Not yet recruiting
- Nasopharyngeal Carcinoma
- (no location specified)
Jan 14, 2022
Metastatic Breast Cancer Trial in Houston (T-DM1, Lapatinib, Abraxane)
Completed
- Metastatic Breast Cancer
- T-DM1
- +2 more
-
Houston, TexasHouston Methodist Hospital
Apr 12, 2019
Drug Interactions Trial in Daytona Beach (Rosuvastatin, Rosuvastatin + BAY1817080)
Completed
- Drug Interactions
- Rosuvastatin
- Rosuvastatin + BAY1817080
-
Daytona Beach, FloridaCovance Clinical Research Unit, Inc.
Mar 9, 2021
Intracranial Atherosclerosis Trial in China (Drug-Eluting Balloon Dilatation Catheter)
Not yet recruiting
- Intracranial Atherosclerosis
- Drug-Eluting Balloon Dilatation Catheter
-
Hefei, Anhui, China
- +10 more
Jul 1, 2021
Cancer Trial (Treatment recommendations made by Molecular Tumor Board.)
Not yet recruiting
- Cancer
- Treatment recommendations made by Molecular Tumor Board.
- (no location specified)
Aug 9, 2022
Methylmalonic Acidemia (MMA) Trial run by the Selecta Biosciences, Inc. (SEL-302)
Recruiting
- Methylmalonic Acidemia (MMA)
-
Bethesda, MarylandNational Human Genome Research Institute, National Institutes of
Mar 9, 2023
Obstructive Sleep Apnea Trial in Boston (Placebo, Acetazolamide, Trazodone)
Not yet recruiting
- Obstructive Sleep Apnea
- Placebo
- +3 more
-
Boston, MassachusettsSleep Disorders Research Program Brigham and Women's Hospital
Jul 18, 2022
COVID19 Trial in Milano (Sarilumab Prefilled Syringe)
Recruiting
- COVID19
- Sarilumab Prefilled Syringe
-
Milano, MI, ItalyDivisione Clinicizzata di Malattie Infettive, ASST FBF-Sacco
Jul 19, 2021
COPD Exacerbation, Air Pollution Trial in Beijing (Budesonide/formoterol, tiotropium bromide)
Completed
- COPD Exacerbation
- Air Pollution
- Budesonide/formoterol
- tiotropium bromide
-
Beijing, Beijing, China
- +10 more
Mar 30, 2022
Metastatic Castration-resistant Prostate Cancer Trial ([177Lu]Ludotadipep 3.7 GBq)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- [177Lu]Ludotadipep 3.7 GBq
- (no location specified)
Jul 12, 2022
Xpert MTB/XDR Clinical Evaluation Trial
Completed
- Tuberculosis, Pulmonary
- Tuberculosis, Multidrug-Resistant
- Cepheid Gene Xpert MTB/XDR
-
Chisinau, Moldova, Republic ofInstitute of Pthisiopenumology
May 17, 2021
Prostate Cancer, Pancreatic Cancer, Bladder Cancer Trial in Los Angeles ([124I] PSCA-Minibody PET/CT imaging of the whole body)
Completed
- Prostate Cancer
- +2 more
- [124I] PSCA-Minibody PET/CT imaging of the whole body
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Jul 23, 2020
Bacteremia, Intensive Care, Critically Ill Trial in Worldwide (7 days of adequate antibiotic treatment, 14 days of adequate
Recruiting
- Bacteremia
- +5 more
- 7 days of adequate antibiotic treatment
- 14 days of adequate antibiotic treatment.
-
New York, New York
- +50 more
Dec 1, 2022
Hypertensive Emergency-associated Hemolytic Uremic Syndrome Trial in Paris (Soliris®, Renin angiotensin system blockers)
Not yet recruiting
- Hypertensive Emergency-associated Hemolytic Uremic Syndrome
- Soliris®
- Renin angiotensin system blockers
-
Paris, FranceTenon Hospital
Feb 3, 2023
Advanced Solid Tumors Trial in China, Korea, Republic of (Tislelizumab, Fruquintinib)
Recruiting
- Advanced Solid Tumors
-
Fuzhou, Fujian, China
- +13 more
Jun 29, 2022
Post Traumatic Stress Disorder Trial in Toronto (MDMA)
Active, not recruiting
- Post Traumatic Stress Disorder
-
Toronto, Ontario, CanadaRemedy Institute
Jan 26, 2023
Ménière's Disease Trial in Munich (Betahistine diHCl, Selegiline-HCl)
Completed
- Ménière's Disease
- Betahistine dihydrochloride
- Selegiline-hydrochloride
-
Munich, Bavaria, GermanyDepartment of Neurology, Ludwig Maximilian University
Jul 10, 2023